company background image
LOTUSEYE logo

Lotus Eye Hospital and Institute NSEI:LOTUSEYE 주식 보고서

최종 가격

₹68.25

시가총액

₹1.4b

7D

2.6%

1Y

-22.1%

업데이트

04 Nov, 2024

데이터

회사 재무

Lotus Eye Hospital and Institute Limited

NSEI:LOTUSEYE 주식 보고서

시가총액: ₹1.4b

LOTUSEYE 주식 개요

안과 전문 병원인 로터스 안과 병원 및 연구소는 인도에서 안과 치료 및 관련 서비스를 제공합니다.

LOTUSEYE 기본 분석
눈송이 점수
가치 평가0/6
미래 성장0/6
과거 실적2/6
재무 상태5/6
배당금0/6

Lotus Eye Hospital and Institute Limited 경쟁사

가격 내역 및 성능

다음에 대한 모든 사상 최고가, 변동 및 가격 하락 요약 Lotus Eye Hospital and Institute
과거 주가
현재 주가₹68.25
52주 최고치₹111.00
52주 최저치₹48.50
베타0.30
11개월 변경-11.92%
3개월 변경 사항8.49%
1년 변경 사항-22.13%
33년 변화54.76%
5년 변화218.18%
IPO 이후 변화91.44%

최근 뉴스 및 업데이트

Optimistic Investors Push Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) Shares Up 25% But Growth Is Lacking

Aug 21
Optimistic Investors Push Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) Shares Up 25% But Growth Is Lacking

Recent updates

Optimistic Investors Push Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) Shares Up 25% But Growth Is Lacking

Aug 21
Optimistic Investors Push Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) Shares Up 25% But Growth Is Lacking

Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) Price Is Out Of Tune With Earnings

Jan 24
Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) Price Is Out Of Tune With Earnings

Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50

Sep 08
Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50

We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease

Jul 15
We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease

Here's Why Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Has Caught The Eye Of Investors

Apr 07
Here's Why Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Has Caught The Eye Of Investors

We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease

Oct 08
We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease

Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50

Sep 02
Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50

If EPS Growth Is Important To You, Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Presents An Opportunity

Jun 17
If EPS Growth Is Important To You, Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Presents An Opportunity

MD & Whole Time Director Sangeetha Sundaramoorthy Just Bought 2.8% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)

Mar 11
MD & Whole Time Director Sangeetha Sundaramoorthy Just Bought 2.8% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)

Chief Executive Officer K. Ramalingam Just Bought 122% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)

Dec 30
Chief Executive Officer K. Ramalingam Just Bought 122% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)

Insider Buying: The Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) MD & Whole Time Director Just Bought 2.8% More Shares

Nov 20
Insider Buying: The Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) MD & Whole Time Director Just Bought 2.8% More Shares

The Chief Executive Officer of Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE), K. Ramalingam, Just Bought 17% More Shares

Sep 21
The Chief Executive Officer of Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE), K. Ramalingam, Just Bought 17% More Shares

Why Investors Shouldn't Be Surprised By Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) P/E

Aug 27
Why Investors Shouldn't Be Surprised By Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) P/E

Should You Take Comfort From Insider Transactions At Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)?

Aug 03
Should You Take Comfort From Insider Transactions At Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)?

Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) P/E Isn't Throwing Up Surprises

Jul 06
Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) P/E Isn't Throwing Up Surprises

주주 수익률

LOTUSEYEIN HealthcareIN 마켓
7D2.6%2.7%1.8%
1Y-22.1%46.4%36.8%

수익률 대 산업: LOTUSEYE underperformed the Indian Healthcare industry which returned 46.4% over the past year.

수익률 대 시장: LOTUSEYE underperformed the Indian Market which returned 36.8% over the past year.

가격 변동성

Is LOTUSEYE's price volatile compared to industry and market?
LOTUSEYE volatility
LOTUSEYE Average Weekly Movement7.4%
Healthcare Industry Average Movement6.1%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.4%
10% least volatile stocks in IN Market4.0%

안정적인 주가: LOTUSEYE has not had significant price volatility in the past 3 months compared to the Indian market.

시간에 따른 변동성: LOTUSEYE's weekly volatility (7%) has been stable over the past year.

회사 소개

설립직원CEO웹사이트
1989336Kuttapalayam Ramalingamwww.lotuseye.org

안과 전문 병원인 로터스 안과 병원 및 연구소는 인도에서 안과 치료 및 관련 서비스를 제공합니다. 이 회사는 리렉스 스마일 라식, 터치 프리 레이저, 라식 눈 수술, 에필라식, 인트라라제, 수프라코어, 로봇 펨토 레이저 백내장 수술, 수정체 유화술, 소아 안과 진료 및 사시 수술, 미세 절개 백내장 수술 치료 등을 제공합니다. 또한 에피지옵틱스, 특수 케르토미터, 시냅토포어, SICS, Phaco, MICS, LRCS, SFLOL, SF IOL 백내장 수술, 각막 패치 이식, 공막 수리, 스크래핑+AMG, 봉합, 타투, 눈물 봉합, 눈물방울 제거, 퍼티지움, C3R, 관통 각막 성형, TPK 및 DALK, DASE; 막 박리 및 엔돌라 레이저를 제공합니다; ERM 제거, 실리콘 오일 및 제거, 유리체절제술 세척, FGE 및 C3F8, LPFC 및 사이클로 크료, 공막 버클 및 벨트 버클, IVTA, 아바스틴, 라주맙, 오주덱스, 자이베브, 아이리아, 루센티스 및 액센트릭스 주사, 섬유주 절제술, 적출, 절제, DCR 및 DCT, PTOSIS 및 측방 타르소라피 서비스 등 다양한 서비스를 제공합니다.

Lotus Eye Hospital and Institute Limited 기본 사항 요약

Lotus Eye Hospital and Institute 의 수익과 매출은 시가총액과 어떻게 비교하나요?
LOTUSEYE 기본 통계
시가총액₹1.42b
수익(TTM)₹21.54m
수익(TTM)₹485.33m

65.9x

P/E 비율

2.9x

P/S 비율

LOTUSEYE 주가가 과대평가되어 있나요?

공정 가치 및 가치 분석 보기

수익 및 수익

최신 수익 보고서의 주요 수익성 통계(TTM)
LOTUSEYE 손익 계산서(TTM)
수익₹485.33m
수익 비용₹354.74m
총 이익₹130.60m
기타 비용₹109.06m
수익₹21.54m

최근 보고된 수익

Jun 30, 2024

다음 수익 날짜

Nov 12, 2024

주당 순이익(EPS)1.04
총 마진26.91%
순이익 마진4.44%
부채/자본 비율1.9%

LOTUSEYE 의 장기적인 성과는 어땠나요?

과거 실적 및 비교 보기